Form 4: Lynx1 Capital Increases Stake in Korro Bio

Lynx1 Capital Management LP acquired 520 additional shares of Korro Bio, Inc. at a price of $10.60 per share.

Summary

• Lynx1 Capital Management LP reported the purchase of 520 shares of Korro Bio, Inc. (KRRO) common stock.
• The transaction occurred on March 31, 2026, at a price of $10.60 per share.
• Following this transaction, the reporting entities beneficially own 1,538,296 shares of Korro Bio, Inc.
• The shares are held directly by Lynx1 Master Fund LP, with Lynx1 Capital Management LP acting as the investment manager.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event; while it indicates institutional support, the transaction size is too small to suggest a material shift in investment strategy.

Positives

• Demonstrates continued confidence from a 10% institutional shareholder through incremental accumulation of equity.

Negatives

• The volume of shares purchased (520) is statistically insignificant relative to the total holdings of 1,538,296 shares.

Risks

• Concentration risk for the reporting entity regarding the performance of Korro Bio, Inc.
• Market volatility affecting the value of the significant equity position held by the reporting person.

Future Outlook

No specific forward-looking guidance or operational outlook was provided in this ownership disclosure.

Industry Context

StockSavvy.ai notes that institutional accumulation, even in small increments, is often viewed as a signal of long-term conviction in the issuer's underlying biotechnology pipeline.

Comparison to Industry Standards

• The filing is a standard regulatory disclosure for 10% owners and does not deviate from typical institutional reporting practices.

Related Party Transactions

• The securities are held by Lynx1 Master Fund LP, managed by Lynx1 Capital Management LP, with Weston Nichols as the sole member of the general partner.

Stakeholder Impact

• Minor positive signal for shareholders regarding institutional commitment to the company.

Next Steps

• Continued monitoring of future Form 4 filings to track potential further accumulation or divestment by Lynx1 Capital Management.

Key Dates

Keywords

Korro Bio, KRRO, Lynx1 Capital Management, Form 4, Insider Trading, Beneficial Ownership